US regulatory body called upon to probe non-disclosure agreements at AI company OpenAI

Whistleblowers recently called upon the U.S. financial regulatory agency to scrutinize OpenAI's historical non-disclosure agreements (NDAs). These documents reportedly included clauses that mandated employees seek permission before interacting with federal authorities, potentially penalizing them for disclosing concerns about the company.

OpenAI, based in San Francisco and recognized as a significant AI entity behind products like ChatGPT, has been at the center of debates on AI's potential risks. The whistleblowers urged immediate investigation into OpenAI's previous NDAs and current compliance with SEC rules by Commissioner Gary Gensler.

On July 1st, a letter detailing this request was shared with Senator Chuck Grassley via the Washington Post after being obtained from his office. The whistleblowers, anonymous in their complaint to the Securities and Exchange Commission (SEC), allege systemic violations at OpenAI affecting workers' federal rights related to whistleblowing.

Accusations include employees signing contracts that waived claims for whistleblower rewards. The letter argues that such NDAs, alongside employment agreements and severance clauses, contravene SEC rules by stipulating communication with regulators be disclosed to the company.

The concerned parties contend it is crucial for employees in AI fields to understand they have a right to raise issues to federal bodies. They urged the SEC to investigate OpenAI's past NDAs, enforce transparency on all issued agreements, reassure former and current staff of their whistleblowing rights, impose fines for unlawful NDAs, and amend practices that may inhibit free discourse about AI advancements.

An OpenAI spokesperson responded by stating the company's commitment to protecting employees' disclosure rights under their whistleblower policy and emphasizing the importance of open discussions regarding AI technology. The SEC was contacted for further comment on this matter.